Literature DB >> 16673879

Plasmid-based assays for DNA end-joining in vitro.

George Iliakis1, Bustanur Rosidi, Minli Wang, Huichen Wang.   

Abstract

Double-strand breaks (DSBs) disrupt DNA integrity and cause genomic instability and cancer, mutations, or cell death. Among the pathways utilized by cells of higher eukaryotes to repair this lesion, nonhomologous end-joining (NHEJ) is the most dominant. The biochemical characterization of NHEJ has significantly benefited from in vitro plasmid end-joining assays that can complement and extend information obtained from genetic studies. There is evidence that several factors involved in DNA-PK-dependent NHEJ remain to be identified. In addition, under certain circumstances, cells utilize backup pathways of NHEJ that depend on unknown factors to remove DSBs. Characterization of these putative factors will benefit from plasmid-based assays of DNA end-joining. Here, we describe a protocol for in vitro end-joining using plasmid DNA as substrate. The required procedures include: (1) preparation of HeLa-cell nuclear extract; (2) preparation of plasmid substrate DNA; (3) assembly of in vitro DNA repair reactions; and (4) product analysis by gel electrophoresis. The assay is powerful and easy to perform, but one should be aware that it represents an oversimplification, as it does not consider the in vivo organization of DNA into chromatin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673879     DOI: 10.1385/1-59259-973-7:123

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.

Authors:  Uday Bhanu Maachani; Tamalee Kramp; Ryan Hanson; Shuping Zhao; Orieta Celiku; Uma Shankavaram; Riccardo Colombo; Natasha J Caplen; Kevin Camphausen; Anita Tandle
Journal:  Mol Cancer Res       Date:  2015-02-26       Impact factor: 5.852

2.  Glycogen synthase kinase 3beta inhibition enhances repair of DNA double-strand breaks in irradiated hippocampal neurons.

Authors:  Eddy S Yang; Somaira Nowsheen; Tong Wang; Dinesh K Thotala; Fen Xia
Journal:  Neuro Oncol       Date:  2011-03-11       Impact factor: 12.300

3.  Modulation of BRCA1 mediated DNA damage repair by deregulated ER-α signaling in breast cancers.

Authors:  Arathi Rajan; Geetu R Varghese; Induprabha Yadev; Jaimie Anandan; Neetha R Latha; Dipyaman Patra; Neethu Krishnan; Krithiga Kuppusamy; Arathy V Warrier; Satej Bhushan; Revathy Nadhan; Ram Mohan Ram Kumar; Priya Srinivas
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

4.  Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.

Authors:  Yanling Wang; Haineng Xu; Tianrun Liu; Menggui Huang; Param-Puneet Butter; Chunsheng Li; Lin Zhang; Gary D Kao; Yanqing Gong; Amit Maity; Constantinos Koumenis; Yi Fan
Journal:  JCI Insight       Date:  2018-02-08

5.  Cdx2 homeoprotein inhibits non-homologous end joining in colon cancer but not in leukemia cells.

Authors:  Benjamin Renouf; Christine Soret; Thoueiba Saandi; François Delalande; Elisabeth Martin; Marie Vanier; Isabelle Duluc; Isabelle Gross; Jean-Noël Freund; Claire Domon-Dell
Journal:  Nucleic Acids Res       Date:  2011-12-20       Impact factor: 16.971

6.  The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation.

Authors:  Quanxin Long; Ran Yan; Jieli Hu; Dawei Cai; Bidisha Mitra; Elena S Kim; Alexander Marchetti; Hu Zhang; Soujuan Wang; Yuanjie Liu; Ailong Huang; Haitao Guo
Journal:  PLoS Pathog       Date:  2017-12-29       Impact factor: 6.823

7.  Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation.

Authors:  Luigi Alfano; Antonella Caporaso; Angela Altieri; Milena Dell'Aquila; Claudia Landi; Luca Bini; Francesca Pentimalli; Antonio Giordano
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

8.  BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer.

Authors:  Yanmei Zhang; Mengdie Fang; Shouye Li; Hao Xu; Juan Ren; Linglan Tu; Bowen Zuo; Wanxin Yao; Guang Liang
Journal:  Mol Cancer       Date:  2022-08-02       Impact factor: 41.444

Review 9.  In vitro non-homologous DNA end joining assays--the 20th anniversary.

Authors:  Elzbieta Pastwa; Richard I Somiari; Mariusz Malinowski; Stella B Somiari; Thomas A Winters
Journal:  Int J Biochem Cell Biol       Date:  2008-12-06       Impact factor: 5.652

10.  PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways.

Authors:  Carole Beck; Christian Boehler; Josée Guirouilh Barbat; Marie-Elise Bonnet; Giuditta Illuzzi; Philippe Ronde; Laurent R Gauthier; Najat Magroun; Anbazhagan Rajendran; Bernard S Lopez; Ralph Scully; François D Boussin; Valérie Schreiber; Françoise Dantzer
Journal:  Nucleic Acids Res       Date:  2014-03-05       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.